Research output per year
Research output per year
Personal profile
External positions
Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Erratum: Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study (PLoS medicine (2022) 19 10 (e1003979))
Hensley, K. S., Jongkees, M. J., Geers, D., GeurtsvanKessel, C. H., Mueller, Y. M., Dalm, V. A. S. H., Papageorgiou, G., Steggink, H., Gorska, A., Bogers, S., den Hollander, J. G., Bierman, W. F. W., Gelinck, L. B. S., Schippers, E. F., Ammerlaan, H. S. M., van der Valk, M., van Vonderen, M. G. A., Delsing, C. E., Gisolf, E. H., Bruns, A. H. W., & 14 others, 1 Jan 2023, In: PLoS Medicine. 20, 1, p. e1004159Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access -
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection
ANRS CO3 Aquitaine Cohort, the Swiss HIV Cohort Study, EuroSIDA & ATHENA Observational Cohort Study, 2023, (E-pub ahead of print) In: Journal of hepatology.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
[18F]FDG-PET/CT in Staphylococcus aureus bacteremia: a systematic review
Buis, D. T. P., Sieswerda, E., Kouijzer, I. J. E., Huynh, W. Y., Burchell, G. L., Berrevoets, M. A. H., Prins, J. M. & Sigaloff, K. C. E., 1 Dec 2022, In: BMC Infectious Diseases. 22, 1, p. 282 282.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Scopus) -
A highly virulent variant of HIV-1 circulating in the Netherlands
Netherlands ATHENA HIV Observational Cohort, BEEHIVE Collaboration & Netherlands ATHENA HIV Observational Cohort†, 4 Feb 2022, In: Science. 375, 6580, p. 540-545 6 p., A30.Research output: Contribution to journal › Article › Academic › peer-review
Open Access14 Citations (Scopus) -
Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial
the Amsterdam UMC COVID-19 Biobank Investigators, 1 Dec 2022, In: Respiratory research. 23, 1, 6 p., 375.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access